Erratum: Pharmacokinetics, Pharmacodynamics, and Safety of Single-Dose Rivaroxaban in Chronic Hemodialysis
Clapton Dias(Janssen (United States)), Kenneth Todd Moore(Bristol-Myers Squibb (United States)), William Smith(SUNY College of Environmental Science and Forestry), Roger M. Mills(Janssen (Belgium)), Jay Ariyawansa(Janssen (United States)), Judy Murphy(University of Auckland)
Cited by 0
Related Papers
Effect of Monthly High-Dose Vitamin D Supplementation on Cardiovascular Disease in the Vitamin D Assessment Study
|JAMA Cardiology|2017|482
Reflex Increase in Coronary Vascular Resistance in Patients with Ischemic Heart Disease
|New England Journal of Medicine|1976|480
Sustained hemodynamic effects of an infusion of nesiritide (human b-type natriuretic peptide) in heart failure
|Journal of the American College of Cardiology|1999|323
Nitroprusside in Critically Ill Patients with Left Ventricular Dysfunction and Aortic Stenosis
|New England Journal of Medicine|2003|278